| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT00134160 |
| P6099 | clinical trial phase | phase IV clinical trial | Q42825046 |
| P17 | country | Japan | Q17 |
| P582 | end time | 2010-05-01 | |
| P4135 | maximum age | 84 | |
| P1050 | medical condition | arterial hypertension | Q41861 |
| P2899 | minimum age | 65 | |
| P1132 | number of participants | 1000 | |
| P4844 | research intervention | calcium oxalate | Q412399 |
| P580 | start time | 2005-08-01 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | The Study Comparing the Incidence of Cardiovascular Events Between High-dose ARB Monotherapy and Combination Therapy With ARB and Calcium Channel Blocker in Japanese Elderly Hypertensive Patients at High Cardiovascular Risk |
Search more.